View by Specialty

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

Steatohepatitis/Metabolic Liver Disease News

SPONSORED CONTENT
Save
SPONSORED CONTENT
August 28, 2018
2 min read
Save

Lifestyle intervention leads to NAFLD remission regardless of obesity

Lifestyle intervention was effective in treating nonalcoholic fatty liver disease in both patients with and without obesity, with weight reduction predicting remission of NAFLD in patients without obesity, according to data published in Journal of Hepatology.

SPONSORED CONTENT
August 24, 2018
1 min read
Save

NASH Network launches real-world evidence pilot study

The NASH Network, in collaboration with the Kinetix Group and partnered with Echosens, launched a real-world evidence study to optimize care delivery for patients with nonalcoholic steatohepatitis, according to a press release.

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

SPONSORED CONTENT
August 22, 2018
2 min read
Save

Early warning score accurately predicts mortality risk in liver disease

The National Early Warning Score accurately identified patients with chronic liver diseases at risk for death, admission to the intensive care unit or cardiac arrest within a 24-hour period, according to a recently published study.

SPONSORED CONTENT
August 21, 2018
1 min read
Save

Simtuzumab ineffective in phase 2b trials for NASH-related fibrosis

Results of two phase 2b trials showed that simtuzumab was ineffective in reducing fibrosis or hepatic venous pressure gradient among patients with bridging fibrosis or cirrhosis associated with nonalcoholic steatohepatitis.

SPONSORED CONTENT
August 16, 2018
2 min read
Save

MELD-Na allocation improves liver transplant waitlist outcomes

Liver allocation based on MELD-Na score improved transplant waitlist outcomes and provided significant benefit to hyponatremic patients, according to recently published data.

SPONSORED CONTENT
August 15, 2018
1 min read
Save

Chronic liver disease hospitalizations outpace other chronic diseases

Patients with chronic liver disease had increasing rates of hospitalization, longer hospital stay, more readmissions and less access to post-acute care compared with patients with other chronic diseases, according to a recently published study.

SPONSORED CONTENT
August 13, 2018
1 min read
Save

Prometic fibrosis candidate reduces hepatic stellate cell activation

Prometic announced that results from recent studies of its lead candidate PBI-4050 showed that the therapy reduced activation of hepatic stellate cells and decreased liver fibrosis through modulation of the LKB1-AMPK-mTOR pathway, according to a press release.

SPONSORED CONTENT
August 09, 2018
3 min read
Save

8 recent reports on grants, approvals in clinical liver research

The FDA recently approved a thrombocytopenia therapy for adults with chronic liver disease and a combination therapy for advanced metastatic hepatocellular carcinoma. Along with these advancements, multiple societies have recently provided grants or investments into liver disease research.

SPONSORED CONTENT
August 09, 2018
2 min read
Save

Primary hypothyroidism associated with increased risk for NAFLD

Primary hypothyroidism associated with increased risk for NAFLD

The presence of primary hypothyroidism is associated with a 42% increased risk for image-defined or biopsy-proven nonalcoholic fatty liver disease, or NAFLD, with risk increasing across different definitions for diagnosing hypothyroidism, according to findings from a meta-analysis published in Thyroid.

SPONSORED CONTENT
August 07, 2018
1 min read
Save

Animal protein linked to NAFLD risk in older, overweight patients

Results of a large population-based study showed that high intake of animal-derived protein correlated with nonalcoholic fatty liver disease among older, overweight Caucasians, independent of well-known risk factors.

View more